Revvity Inc (RVTY)
Industry Diagnostics & Research
This stock can be held in an Investment ISA and an Investment Account
Sell
$93.92
Buy
$98.94
$0.39 (+0.41%)
Prices updated at 19 May 2026, 22:26 EDT
| Prices minimum 15 mins delay
Prices in USD
PerkinElmer Inc is a diagnostics company that provides instruments, consumables, and services to biomedical, chemical and to general industrial markets. It operates in two segments namely Discovery and Analytical Solutions and Diagnostics.
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
- Key stats
- Price
- Fair value
- Dividends
- News
- Financials
- Valuation
- Profile
Income statement
Year | 2024 | 2025 |
|---|---|---|
| 2,755m | 2,856m | |
| 1,538m | 1,564m | |
| 347m | 357m | |
| 12.59 | 12.49 | |
| 270m | 241m | |
| 840m | 766m | |
| Sales, General and administrative | 994m | 992m |
| Interest expenses | 96m | 92m |
| Provision for income taxes | 33m | 28m |
| Operating expenses | 1,191m | 1,208m |
| Income before taxes | 316m | 268m |
| Net income available to common shareholders | 270m | 241m |
| 2.21 | 2.07 | |
| Net interest income | -23m | -61m |
| Advertising and promotion | - | - |
| Net investment income, net | - | - |
| Realised capital gains (losses), net | - | - |
| Total benefits, claims and expenses | - | - |
| Earnings per share (diluted) | 2.2 | 2.07 |
| Free cash flow per share | 4.5768 | 4.1931 |
| Book value/share | 65.6607 | 65.6914 |
| Debt equity ratio | 0.430682 | 0.383339 |
Balance sheet
Year | 2024 | 2025 |
|---|---|---|
| Current assets | 2,350m | 2,240m |
| Current liabilities | 653m | 1,331m |
| Total capital | 10,817m | 9,882m |
| Total debt | 3,326m | 3,398m |
| Total equity | 7,667m | 7,250m |
| Total non current liabilities | - | - |
| Loans | 3,150m | 2,631m |
| Total assets | 12,392m | 12,168m |
| Total liabilities | - | - |
| Cash and cash equivalents | 1,163m | 920m |
| Common stock | 121m | 112m |
Cash flow
Year | 2024 | 2025 |
|---|---|---|
| Cash at beginning of period | 914m | 1,164m |
| Cash dividends paid | -34m | -33m |
| 542m | 509m | |
| Investments (gains) losses | 776m | -17m |
| 1,164m | 921m | |
| Net income | - | - |
| 628m | 583m | |
| -87m | -74m |
The figures shown in the tables are quoted in the currency of the stock selected.
Please note that past performance is not a reliable indicator of future returns. Please use the interactive graph for benchmark comparison.